ArticleJournal of current glaucoma practice
Spectralis OCT1 versus OCT2: Time Efficiency and Image Quality of Retinal Nerve Fiber Layer Thickness and Bruch's Membrane Opening Analysis for Glaucoma Patients.
Article in Journal of current glaucoma practice. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed, 10 citations in OpenAlex.
- Avoiding False-Positive Glaucoma Diagnosis in Myopic Eyes: Clinical Importance of OCT Scan Diameter.Journal of clinical medicine · 2026Article
- Optical coherence tomography acquisition efficiency: comparison of Heidelberg spectralis OCT2 module & Zeiss Cirrus HD-OCT model 6000.Frontiers in ophthalmology · 2026Article
- Quantitative Analysis of Retinal Nerve Fiber Layer Thickness Using SPECTRALIS Glaucoma Module Premium Edition and SPECTRALIS Standard Glaucoma Module.Translational vision science & technology · 2025Article
- Recent Optical Coherence Tomography (OCT) Innovations for Increased Accessibility and Remote Surveillance.Bioengineering (Basel, Switzerland) · 2025Review
- Automated evaluation of retinal hyperreflective foci changes in diabetic macular edema patients before and after intravitreal injection.Frontiers in medicine · 2023Article
- Implementation of Lean healthcare methodology in designing an Intravitreal Injection Center: first Italian experience.International ophthalmology · 2020Article
- A Reflectivity Measure to Quantify Bruch's Membrane Calcification in Patients with Pseudoxanthoma Elasticum Using Optical Coherence Tomography.Translational vision science & technology · 2020Article
- Lean approach to the management of patients undergoing intravitreal injections during COVID-19 pandemic.Therapeutic advances in ophthalmologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo compare two generations of Heidelberg SPECTRALIS optical coherence tomography (OCT) technologies (SPECTRALIS OCT1 and OCT2) with regard to time efficiency and image quality of retinal nerve fiber layer (RNFL) thickness and Bruch's membrane opening (BMO) analysis in individuals with glaucoma. MATERIALS AND
methodsIn this single center, prospective cohort study, 35 consecutive glaucoma patients (70 eyes) were included. RNFL thickness and BMO-MRW analysis was performed in all patients using the Heidelberg SPECTRALIS OCT1 and the Heidelberg SPECTRALIS OCT2 module. Each patient was imaged three times both with the SPECTRALIS-OCT1 and the SPECTRALIS-OCT2 device. All scans were assessed for further analyzability. Acquisition duration, signal-to-noise ratio (SNR), and the displacement between the initially localized and the redetermined BMO center were extracted from the measurement protocols and statistically compared.
resultsMean (cumulative) scan acquisition duration was significantly higher with OCT1 compared with OCT2 (54.80 ± 18.61 seconds vs 20.40 ± 6.61 seconds;
conclusionWith SPECTRALIS OCT2, acquisition time of BMO and RNFL scans is less than half of the acquisition time of SPECTRALIS OCT1. Image quality of OCT2 module is at least equivalent to the image quality of OCT1. HOW TO CITE THIS ARTICLE: Bosche F, Andresen J,
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.